Aridis Pharmaceuticals, Inc.
6 clinical trials · Sponsor
◉ Watch Aridis Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2 (NCT05331885) | Aridis Pharmaceuticals, Inc. | 2022-09-02 |
| Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 (NCT03816956) | Aridis Pharmaceuticals, Inc. | 2019-05-03 |
| SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects (NCT03669614) | Aridis Pharmaceuticals, Inc. | 2018-12-07 |
| Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia (NCT03027609) | Aridis Pharmaceuticals, Inc. | 2017-03-29 |
| Study of Single Doses of IV Aerucin in Healthy Adults (NCT02486770) | Aridis Pharmaceuticals, Inc. | 2015-04-01 |
| Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus) (NCT01589185) | Aridis Pharmaceuticals, Inc. | 2012-05-01 |
Track Aridis Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.